In a aptient population, coordinated use of digital rectal examination and prostate-specific antigen can alert the physician as to the possible existence of prostate cancer. If both are used as first-line studies, abnormality of either can then direct the need for further study by transrectal ultras
Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection
✍ Scribed by J.B.W. RIETBERGEN; R. KRANSE; W.J. KIRKELS; H.J. DE KONING; F H SCHRÖDER
- Book ID
- 109050738
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 673 KB
- Volume
- 79
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. The 11,811 first visits and 46,751 annual follow-up visits performed since 1988 were analyzed in order to assess the efficacy of serum prostatic specific antigen (PSA) and digital rectal examination (DRE) for diagnosis of prostate cancer. METHODS. At first visit, screening included
Over a 4% year period, 1,940 asymptomatic men were entered in a prostate cancer detection program consisting of digital rectal examination (DRE), prostate-specific antigen (PSA), and transrectal prostate ultrasound (TRUS). Four hundred and sixteen biopsies were performed resulting in the diagnosis o
In a study population, can digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA) (monoclonal) effectively detect the majority of clinically relevant cancer? If this is possible, the remaining patients could then be considered for chemopreventive protoco